Why would you promote something that is less percent safer than a condom

New biomedical prevention technologies (NPTs) for HIV, including oral Pre-Exposure Prophylaxis, and vaginal and rectal microbicides and HIV vaccines in development, may contribute substantially to controlling the HIV epidemic. However, their effectiveness is contingent on product acceptability and adherence. We explored perceptions and understanding of partially effective NPTs with key populations in South African townships. From October 2013 to February 2014, we conducted six focus groups and 18 individual interviews with Xhosa-speaking adolescents (n = 14), adult men who have sex with men (MSM) (n = 15), and adult heterosexual men (n = 9) and women (n = 10), and eight key informant (KI) interviews with healthcare workers. Interviews/focus groups were transcribed and reviewed using a thematic approach and framework analysis. Overall, participants and KIs indicated scepticism about NPTs that were not 100% efficacious. Some participants equated not being 100% effective with not being completely safe, and thus not appropriate for dissemination. KIs expressed concerns that promoting partially effective NPTs would encourage substitution of a more effective with a less effective method or encourage risk compensation. Educational and social marketing interventions that address the benefits and appropriate use of partially effective NPTs, including education and support tailored for frontline service providers, are needed to prepare for successful NPT implementation in South Africa

Business · Condom · Environmental health · Family medicine · Focus group · Men who have sex with men · Microbicides for sexually transmitted diseases · Population · Psychological intervention · Qualitative research · Social marketing · Sociology · Thematic analysis · Adolescent Sexual and Reproductive Health · HIV/AIDS Research and Interventions · Medicine · Nursing · Vaccine Coverage and Hesitancy · Marketing

• Characterising concerns and misinformation shaping global HIV vaccine confidence and demand

  Open Access•Simamkele Bokolo, Megan Rabin et al.•BMJ Global Health•2026

  Añadir item

• “ It’s Almost as if Stakeholder Engagement is the Annoying ‘Have-to-do'… ”

  Open Access•Abigail Wilkinson, C Slack et al.•Journal of Empirical Research on…•2022

  Añadir item

• Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial

  Open Access•Juliane Etima, Ariana Katz et al.•AIDS and Behavior•2021

  Añadir item

• Women’s Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP

  Open Access•Scarlett Bergam, Anna Harrison et al.•AIDS and Behavior•2022

  Añadir item

• Campus healthcare workers’ knowledge and views on injectable pre-exposure prophylaxis prior to rollout in South Africa

  Open Access•Nomvuselelo Nomzamo Mbatha, Nomakhosi Mpofana et al.•PLOS Global Public Health•2026

  Añadir item

• Effectiveness and safety of oral HIV preexposure prophylaxis for all populations

  Open Access•Virginia A Fonner, Sarah L Dalglish et al.•AIDS•2016

  Añadir item

• Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

  Jared M Baeten, Thesla Palanee‐phillip et al.•New England Journal of Medicine•2016

  Añadir item

• Civil society perspectives on negative biomedical HIV prevention trial results and implications for future trials

  Zaynab Essack, Jennifer Koen et al.•AIDS Care•2012

  Añadir item

• Understanding the partial protection of male circumcision for HIV prevention among women in Iringa Region, Tanzania

  Erica H Layer, SW Beckham et al.•AIDS Care•2013

  Añadir item

• If It’s Not Working, Why Would They Be Testing It?”

  Open Access•Venkatesan Chakrapani, P A Newman et al.•BMC Public Health•2013

  Añadir item

• Acceptability and Preferences for Hypothetical Rectal Microbicides among a Community Sample of Young Men Who Have Sex with Men and Transgender Women in Thailand

  Open Access•P A Newman, Michael P Cameron et al.•AIDS and Behavior•2015

  Añadir item

• Explaining the Efficacy of Pre-exposure Prophylaxis (PrEP) for HIV Prevention

  Open Access•K Underhill, Kathleen M Morrow et al.•AIDS and Behavior•2015

  Añadir item

• Risk, safety and sex among male PrEP users

  Kimberly A Koester, Kimberly Koester et al.•Culture Health & Sexuality•2017

  Añadir item

• Beyond the Distinction Between Biomedical and Social Dimensions of HIV Prevention Through the Lens of a Social Public Health

  Susan Kippax, Niamh Stephenson•American Journal of Public Health•2012

  Añadir item

• Perceptions of Sexual Risk Compensation Following Posttrial HIV Vaccine Uptake Among Young South Africans

  Open Access•Catherine L Macphail, Catherine Macphail et al.•Qualitative Health Research•2012

  Añadir item